0000899243-18-009117.txt : 20180402
0000899243-18-009117.hdr.sgml : 20180402
20180402201213
ACCESSION NUMBER: 0000899243-18-009117
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180329
FILED AS OF DATE: 20180402
DATE AS OF CHANGE: 20180402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Makker Gotham
CENTRAL INDEX KEY: 0001726391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 18731009
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-29
0
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001726391
Makker Gotham
C/O ROCKET PHARMACEUTICALS, INC.
430 EAST 29TH STREET, SUITE 1040
NEW YORK
NY
10016
1
0
0
0
Stock Option (Right to Buy)
18.75
2018-03-29
4
A
0
40000
0.00
A
2028-03-29
Common Stock
40000
40000
D
Stock Option (Right to Buy)
18.75
2018-03-29
4
A
0
3300
14.09
A
2028-03-29
Common Stock
3300
3300
D
This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 13,336 of which will become fully vested and exercisable on March 29, 2019, with the remaining 26,664 shares vesting in equal monthly installments over the following two years.
This option represents a right to purchase a total of 3,300 shares of the Issuer's Common Stock, 1,116 of which will become fully vested and exercisable on March 29, 2019, with the remaining 2,184 shares vesting in equal monthly installments over the following two years. This option was issued to the Reporting Person in lieu of director retainer fees of $46,500.
/s/ Alice Lee, as attorney-in-fact for Gotham Makker
2018-04-02